If weight loss is shown to favorably affect survival prognosis among breast cancer patients, CHOICE findings fail to provide strong support for investigating a causal linkage between adiponectin or leptin and changes in prognosis mediated by weight loss. The gene discussed is ADIPOQ; the disease is breast carcinoma.